Abstract
The metabolism of arachidonic acid (AA) in fragments of lactating rabbit mammary glands in vitro was studied by considering the distribution of 13-{ 14C}AA in the cells, and the effects of inhibitors of cyclooxygenase and lipoxygenase pathway on the basal and prolactin (PRL)-stimulated casein secretion. 13-{ 14C}AA was incorporated in all classes of lipids and PRL increased transiently the percentage of free fatty acid after 1 and 5 min. Ten μM ETYA (5,8,11,14-Eicosatetraynoic acid), a tetrayne analogue of AA inhibited prostaglandins F 2α (PGF 2α) production but not leukotrienes B 4 and C 4 (LTB 4 and LTC 4) production and increased basal casein secretion. 10 −4 M DCHA (Docosahexaenoic acid) a competitive inhibitor of prostaglandin-synthetase inhibited PGF 2α production but did not affect basal nor PRL-stimulated casein secretion. Fourteen μM indomethacin inhibited PFF 2α and LTC 4 production and PRL-stimulated casein secretion. Ten μM NGDA (nordihydroguaiaretic acid) an inhibitor of lipoxygenase pathway, inhibited LTB 4 and LTC 4 production, increased basal level of casein secretion and inhibited PRL-stimulated casein secretion. Hundred μM caffeic acid, an inhibitor of glutathion-S-transferase (GST), a class of enzymes implied in the transformation of LTA 4 into LTC 4, had the same effect that NDGA on basal and PRL-stimulated casein secretion. These findings show that inhibitors of AA metabolites alter casein secretion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.